|
Re: My conversation with Don....
|
2
|
Resverlogix Corp.
|
Dec 02, 2017 09:15AM
|
|
Re: VP of clinical operations
|
2
|
Zenith Epigenetics
|
May 21, 2023 06:26PM
|
|
Re: Expectations for the AGM?
|
2
|
Zenith Epigenetics
|
Dec 10, 2020 12:18PM
|
|
Is this short selling or covering
|
2
|
Resverlogix Corp.
|
May 31, 2018 02:13PM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
2
|
Zenith Epigenetics
|
Aug 18, 2020 04:32PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
2
|
Zenith Epigenetics
|
Oct 08, 2024 11:20AM
|
|
Re: Some idle speculation I just can't resist.....
|
2
|
Resverlogix Corp.
|
Aug 26, 2016 11:15AM
|
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jul 22, 2022 02:40PM
|
|
Here's a thought, speculation
|
2
|
Resverlogix Corp.
|
Jan 14, 2017 01:55PM
|
|
Re: This raises more questions than it answers...
|
2
|
Resverlogix Corp.
|
Apr 21, 2017 07:26PM
|
|
Re: Here's a cut and paste from SEDAR....
|
2
|
Resverlogix Corp.
|
Aug 22, 2016 08:51PM
|
|
Re: Leak? SP up 51% !
|
2
|
Resverlogix Corp.
|
Apr 04, 2023 11:39AM
|
|
Re: RBC unregistered to registered account
|
2
|
Zenith Epigenetics
|
Mar 29, 2019 07:14AM
|
|
Re: Additional Exempt Distribution- 2023-03-31
|
2
|
Zenith Epigenetics
|
Apr 17, 2023 07:01AM
|
|
Re: Gilead GS-5829 Perspective
|
2
|
Zenith Epigenetics
|
Jul 24, 2017 12:41PM
|
|
Re: Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Feb 24, 2023 11:27AM
|
|
Re: New blog posting about RVX...
|
2
|
Resverlogix Corp.
|
Sep 11, 2016 08:16AM
|
|
Re: Edmonton Journal Article
|
2
|
Resverlogix Corp.
|
Jan 19, 2022 12:10PM
|
|
Re: This week could be very telling....
|
2
|
Resverlogix Corp.
|
Sep 25, 2016 09:30AM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 11:50AM
|
